CuraSen Therapeutics, Inc.
San Carlos, US · Founded 2016 · Delaware corporation · 20 employees on LinkedIn · 3 known investors
Find your way into CuraSen Therapeutics, Inc.
Founders & leadership
CuraSen Therapeutics, Inc. was founded in 2016 by Anthony P. Ford.
AP
BP
Benjamin PotterExecutive
HS
Henry SkinnerNamed on SEC filing
LR
Board
Investors · 3
Also in the syndicate · 1
Alzheimer’s Drug Discovery Foundation (ADDF)
Reported raises · per SEC filings
Form D private placements$68.6M disclosed across 4 of 5 rounds · 2018–2024
▶$5.8MraisedSep 2024 · 7 investors · BiotechnologyRule 506(b)
▶$5.8MraisedSep 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ron HuntDirector
- Anthony P. FordExecutive Officer, Director
- Benjamin PotterExecutive Officer
- Loretta Tse, Ph.D.Director
- Kathleen Sereda GlaubDirector
- Simon Tate, Ph.D.Director
- Patrick EnrightDirector
- Offering amount
- $45.7M
- Amount sold
- $5.8M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.6MraisedOct 2023 · 11 investors · BiotechnologyRule 506(b)
▶$17.6MraisedOct 2023 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony P. FordDirector, Executive Officer
- Simon TateDirector
- Patrick EnrightDirector
- Loretta Tse, Ph.D.Director
- Benjamin PotterExecutive Officer
- Kathleen Sereda GlaubDirector
- Ron HuntDirector
- Offering amount
- $20.8M
- Amount sold
- $17.6M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedNov 2021 · 10 investors · BiotechnologyRule 506(b)
▶$18MraisedNov 2021 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick EnrightDirector
- Benjamin PotterExecutive Officer
- Anthony P FordDirector, Executive Officer
- Ron HuntDirector
- Loretta Tse, Ph.D.Director
- Simon TateDirector
- Kathleen Sereda GlaubDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.2MraisedJan 2019 · 10 investors · BiotechnologyRule 506(c)
▶$27.2MraisedJan 2019 · 10 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Henry SkinnerDirector
- Patrick EnrightDirector
- Liam RatcliffeDirector
- Benjamin PotterExecutive Officer
- Anthony P. FordExecutive Officer, Director
- Kathleen Sereda GlaubDirector
- Offering amount
- $54.5M
- Amount sold
- $27.2M
- Minimum investment
- $1
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded CuraSen Therapeutics, Inc.?
- CuraSen Therapeutics, Inc. was founded by Anthony P. Ford in 2016.
- Who are CuraSen Therapeutics, Inc.'s investors?
- CuraSen Therapeutics, Inc.'s investors include Alta Partners, New Leaf Venture Partners.
- How much funding has CuraSen Therapeutics, Inc. raised?
- CuraSen Therapeutics, Inc. has disclosed $68.6M raised across 4 of its 5 known rounds.
- Where is CuraSen Therapeutics, Inc. headquartered?
- CuraSen Therapeutics, Inc. is headquartered in San Carlos, US.